Valeo Pharma Inc. announced that it has entered into a credit facility agreement with Accord Financial Inc. The $5 million credit facility is secured by a first rank lien on the Corporation's short term assets, and bears interest at the Scotiabank's prime rate plus an applicable margin. Borrowings under the credit facility are expected to be used for working capital and other general corporate purposes.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 CAD | +21.05% | -4.17% | -36.11% |
Apr. 25 | Transcript : Valeo Pharma Inc. - Shareholder/Analyst Call | |
Mar. 22 | Valeo Pharma Inc. Announces Appointment of Al Moghaddam to Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.11% | 8.29M | |
+25.83% | 661B | |
+27.19% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.55% | 231B | |
+4.47% | 200B | |
-9.45% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- VPH Stock
- News Valeo Pharma Inc.
- Valeo Pharma Enters into $5 Million Credit Facility Agreement with Accord Financial Inc